The secrets of dermcidin action

International Journal of Medical Microbiology

Volumn 305, Issue 2, 2015, Pages 283-286

  Burian, Marc ^a   Schittek, Birgit ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antimicrobial peptides; Dermcidin; Ion channel; Oligomerization; Staphylococcus aureus

Indexed keywords

AMINO ACID; DCD 1 PEPTIDE; DCD 1L PEPTIDE; DERMCIDIN; ION CHANNEL; PEPTIDE; PHOSPHOLIPID; UNCLASSIFIED DRUG; ZINC; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIMICROBIAL ACTIVITY; BACTERIAL CELL; BACTERIAL MEMBRANE; BACTERIUM IDENTIFICATION; CELL DEATH; CELL STRUCTURE; HUMAN; MEMBRANE DEPOLARIZATION; PROTEIN LIPID INTERACTION; SHORT SURVEY; ANIMAL; BACTERIUM; CELL MEMBRANE; DRUG EFFECTS; METABOLISM; MICROBIAL VIABILITY; PROTEIN MULTIMERIZATION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CELL MEMBRANE; HUMANS; ION CHANNELS; MICROBIAL VIABILITY; PEPTIDES; PHOSPHOLIPIDS; PROTEIN MULTIMERIZATION;

EID: 84977814228     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.12.012     Document Type: Short Survey

References (27)

1. 2+ on its interaction with a biomimetic membrane. Soft Matter 2014, 10:616-626.
2. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
3. Burian M., Velic A., Matic K., Günther S., Kraft B., Gonser L., Forchhammer S., Tiffert Y., Naumer C., Krohn M., Berneburg M., Yazdi A.S., Macek B., Schittek B. Quantitative proteomics of the human skin secretome reveal a reduction of immune defense mediators in ectodermal dysplasia patients. J. Invest. Dermatol. 2014, [Epub ahead of print]. 10.1038/jid.2014.462.
4. Cipakova I., Gasperik J., Hostinova E. Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. Protein Expr. Purif. 2006, 45:269-274.
5. Jung H.H., Yang S.T., Sim J.Y., Lee S., Lee J.Y., Kim H.H., Shin S.Y., Kim J.I. Analysis of the solution structure of the human antibiotic peptide dermcidin and its interaction with phospholipid vesicles. BMB Rep. 2010, 43:362-368.
6. Lai Y., Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30:131-141.
7. Lai Y., Villaruz A.E., Li M., Cha D.J., Sturdevant D.E., Otto M. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 2007, 63:497-506.
8. Lai Y.P., Peng Y.F., Zuo Y., Li J., Huang J., Wang L.F., Wu Z.R. Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide. Biochem. Biophys. Res. Commun. 2005, 328:243-250.
9. Li M., Rigby K., Lai Y., Nair V., Peschel A., Schittek B., Otto M. Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids. Antimicrob. Agents Chemother. 2009, 53:4200-4210.
10. Paulmann M., Arnold T., Linke D., Ozdirekcan S., Kopp A., Gutsmann T., Kalbacher H., Wanke I., Schuenemann V.J., Habeck M., Burck J., Ulrich A.S., Schittek B. Structure-activity analysis of the dermcidin-derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat. J. Biol. Chem. 2012, 287:8434-8443.
11. Peschel A., Jack R.W., Otto M., Collins L.V., Staubitz P., Nicholson G., Kalbacher H., Nieuwenhuizen W.F., Jung G., Tarkowski A., van Kessel K.P., van Strijp J.A. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 2001, 193:1067-1076.
12. Peschel A., Otto M., Jack R.W., Kalbacher H., Jung G., Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 1999, 274:8405-8410.
13. Rieg S., Seeber S., Steffen H., Humeny A., Kalbacher H., Stevanovic S., Kimura A., Garbe C., Schittek B. Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J. Invest. Dermatol. 2006, 126:354-365.
14. Rieg S., Steffen H., Seeber S., Humeny A., Kalbacher H., Dietz K., Garbe C., Schittek B. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J. Immunol. 2005, 174:8003-8010.
15. Sagawa K., Kimura A., Saito Y., Inoue H., Yasuda S., Nosaka M., Tsuji T. Production and characterization of a monoclonal antibody for sweat-specific protein and its application for sweat identification. Int. J. Legal Med. 2003, 117:90-95.
16. Sakurada K., Akutsu T., Fukushima H., Watanabe K., Yoshino M. Detection of dermcidin for sweat identification by real-time RT-PCR and ELISA. Forensic Sci. Int. 2010, 194:80-84.
17. Schittek B. The multiple facets of dermcidin in cell survival and host defense. J. Innate Immun. 2012, 4:349-360.
18. Schittek B., Hipfel R., Sauer B., Bauer J., Kalbacher H., Stevanovic S., Schirle M., Schroeder K., Blin N., Meier F., Rassner G., Garbe C. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2001, 2:1133-1137.
19. Senyurek I., Döring G., Kalbacher H., Deeg M., Peschel A., Wolz C., Schittek B. Resistance to dermcidin-derived peptides is independent of bacterial protease activity. Int. J. Antimicrob. Agents 2009, 34:86-90.
20. Senyurek I., Paulmann M., Sinnberg T., Kalbacher H., Deeg M., Gutsmann T., Hermes M., Köhler T., Götz F., Wolz C., Peschel A., Schittek B. Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Antimicrob. Agents Chemother 2009, 53:2499-2509.
21. Song C., Weichbrodt C., Salnikov E.S., Dynowski M., Forsberg B.O., Bechinger B., Steinem C., de Groot B.L., Zachariae U., Zeth K. Crystal structure and functional mechanism of a human antimicrobial membrane channel. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:4586-4591.
22. Steffen H., Rieg S., Wiedemann I., Kalbacher H., Deeg M., Sahl H.G., Peschel A., Gotz F., Garbe C., Schittek B. Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob. Agents Chemother. 2006, 50:2608-2620.
23. van Dam A., Aalders M.C., van Leeuwen T.G., Lambrechts S.A. The compatibility of fingerprint visualization techniques with immunolabeling. J. Forensic Sci. 2013, 58:999-1002.
24. Vuong C., Voyich J.M., Fischer E.R., Braughton K.R., Whitney A.R., DeLeo F.R., Otto M. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 2004, 6:269-275.
25. Walther T.H., Gottselig C., Grage S.L., Wolf M., Vargiu A.V., Klein M.J., Vollmer S., Prock S., Hartmann M., Afonin S., Stockwald E., Heinzmann H., Nolandt O.V., Wenzel W., Ruggerone P., Ulrich A.S. Folding and self-assembly of the TatA translocation pore based on a charge zipper mechanism. Cell 2013, 152:316-326.
26. Yeaman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55:27-55.
27. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.